TY - JOUR
T1 - Digital ulcers predict a worse disease course in patients with systemic sclerosis
AU - EUSTAR
AU - Mihai, Carina
AU - Landewé, Robert
AU - Van Der Heijde, Désirée
AU - Walker, Ulrich A.
AU - Constantin, Paul I.
AU - Gherghe, Ana Maria
AU - Ionescu, Ruxandra
AU - Rednic, Simona
AU - Allanore, Yannick
AU - Avouac, Jérôme
AU - Czirják, László
AU - Hachulla, Eric
AU - Riemekasten, Gabriela
AU - Cozzi, Franco
AU - Airò, Paolo
AU - Cutolo, Maurizio
AU - Mueller-Ladner, Ulf
AU - Matucci-Cerinic, Marco
AU - Launay, David
AU - Dobrota, Rucsandra
AU - Sfrent-Cornateanu, Roxana
AU - Zingarelli, Stefania
AU - Pigatto, Erika
AU - Cuomo, Giovanna
AU - Caramaschi, Paola
AU - Ananieva, Lidia
AU - Ullman, Susanne
AU - Iversen, Line
AU - Gurman, Alexandra Balbir
AU - Braun-Moscovici, Yolanda
AU - Carreira, Patricia E.
AU - Joven, Beatriz E.
AU - Minier, Tünde
AU - Guiducci, Serena
AU - Bellando-Randone, Silvia
AU - Pellerito, Raffaele
AU - Hunzelmann, Nicolas
AU - Tarner, Ingo H.
AU - Radominski, Sebastião Cezar
AU - De Souza Müller, Carolina
AU - Iannone, Florenzo
AU - Henes, Jörg
AU - Bancel, Dominique Farge
AU - Damjanov, Nemanja
AU - Ostojic, Predrag
AU - Pozzi, Maria Rosa
AU - Hesselstrand, Roger
AU - Denton, Christopher
AU - Krasowska, Dorota
AU - Tikly, Mohammed
N1 - Funding Information:
Funding EUSTAR is supported by EULAR.
Copyright:
Copyright 2019 Elsevier B.V., All rights reserved.
PY - 2016/4
Y1 - 2016/4
N2 - Objective: Systemic sclerosis (SSc) is a systemic autoimmune disease with high morbidity and significant mortality. There is a great need of predictors that would allow risk stratification of patients with SSc and ultimately initiation of treatment early enough to ensure optimal clinical results. In this study, we evaluated whether a history of digital ulcers (HDU) at presentation may be a predictor of vascular outcomes and of overall clinical worsening and death in patients with SSc. Methods: Patients from the EULAR Scleroderma Trials and Research (EUSTAR) database, satisfying at inclusion the 1980 American College of Rheumatology classification criteria for SSc, who had a follow-up of at least 3 years since baseline or who have died, were included in the analysis. HDU at presentation as a predictor of disease worsening or death was evaluated by Cox proportional hazards regression analysis. Results :3196 patients matched the inclusion criteria (male sex 13.2%, 33.4% diffuse subset). At presentation, 1092/3196 patients had an HDU (34.1%). In multivariable analysis adjusting for age, gender and all parameters considered potentially significant, HDU was predictive for the presence of active digital ulcers (DUs) at prospective visits (HR (95% CI)): 2.41(1.91 to 3.03), p<0.001, for an elevated systolic pulmonary arterial pressure on heart ultrasound (US-PAPs):1.36 (1.03 to 1.80), p=0.032, for any cardiovascular event (new DUs, elevated US-PAPs or LV failure):3.56 (2.26 to 5.62), p<0.001, and for death (1.53 (1.16 to 2.02), p=0.003). Conclusions :In patients with SSc, HDU at presentation predicts the occurrence of DUs at follow-up and is associated with cardiovascular worsening and decreased survival.
AB - Objective: Systemic sclerosis (SSc) is a systemic autoimmune disease with high morbidity and significant mortality. There is a great need of predictors that would allow risk stratification of patients with SSc and ultimately initiation of treatment early enough to ensure optimal clinical results. In this study, we evaluated whether a history of digital ulcers (HDU) at presentation may be a predictor of vascular outcomes and of overall clinical worsening and death in patients with SSc. Methods: Patients from the EULAR Scleroderma Trials and Research (EUSTAR) database, satisfying at inclusion the 1980 American College of Rheumatology classification criteria for SSc, who had a follow-up of at least 3 years since baseline or who have died, were included in the analysis. HDU at presentation as a predictor of disease worsening or death was evaluated by Cox proportional hazards regression analysis. Results :3196 patients matched the inclusion criteria (male sex 13.2%, 33.4% diffuse subset). At presentation, 1092/3196 patients had an HDU (34.1%). In multivariable analysis adjusting for age, gender and all parameters considered potentially significant, HDU was predictive for the presence of active digital ulcers (DUs) at prospective visits (HR (95% CI)): 2.41(1.91 to 3.03), p<0.001, for an elevated systolic pulmonary arterial pressure on heart ultrasound (US-PAPs):1.36 (1.03 to 1.80), p=0.032, for any cardiovascular event (new DUs, elevated US-PAPs or LV failure):3.56 (2.26 to 5.62), p<0.001, and for death (1.53 (1.16 to 2.02), p=0.003). Conclusions :In patients with SSc, HDU at presentation predicts the occurrence of DUs at follow-up and is associated with cardiovascular worsening and decreased survival.
UR - http://www.scopus.com/inward/record.url?scp=84930163748&partnerID=8YFLogxK
U2 - 10.1136/annrheumdis-2014-205897
DO - 10.1136/annrheumdis-2014-205897
M3 - Journal articles
C2 - 25688073
AN - SCOPUS:84930163748
SN - 0003-4967
VL - 75
SP - 681
EP - 686
JO - Annals of the Rheumatic Diseases
JF - Annals of the Rheumatic Diseases
IS - 4
ER -